On July 3rd, Goldman Sachs raised the target price of Eli Lilly and Co from $785 to $793 and maintained a "neutral" rating.
高盛上调礼来目标价至793美元
Goldman Sachs raised the target price of Eli Lilly and Co. to $793.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.